Correspondence to Escape Velocity-The Launch of Microbiome Therapies .

Details

• Alternative Title:
  The Journal of Infectious Diseases, 2025, v. 231, no. 2: Correspondence to Escape Velocity-The Launch of Microbiome Therapies .
• Journal Article:
  The Journal of Infectious Diseases
• Personal Author:
  Olle, Bernat ; Ranallo, Ryan ; McDonald, L. Clifford
• Description:
  Letter to the editor in response to Kelly BJ, Kwon JH, Woodworth MH. Escape Velocity-the Launch of Microbiome Therapies. J Infect Dis. 2024 Jul 25;230(1):2-4. doi: 10.1093/infdis/jiae099. PMID: 39052747; PMCID: PMC11272035. This letter clarifies terminology regarding live biotheraputic products.
• Content Notes:
  Author manuscript
• Subjects:
  • Humans
  • Clostridioides difficile
  • Fecal Microbiota Transplantation
  • Translational Research, Biomedical
  • Microbiota
• Source:
  The Journal of Infectious Diseases, 2025, v. 231, no. 2
• DOI:
  https://doi.org/10.1093/infdis/jiae575
• ISSN:
  0022-1899 ; 1537-6613
• Pubmed ID:
  39565899
• Pubmed Central ID:
  PMC12486162
• Document Type:
  Text
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Corporate as Subject:
  United States Food and Drug Administration
• Genre:
  Journal Article
• Pages in Document:
  544 (2 pdf pages)
• Volume:
  231
• Issue:
  2
• Download URL:
  https://stacks.cdc.gov/view/cdc/261917/cdc_261917_DS1.pdf
• File Type:
  [PDF - 33.64 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:00488f59537c69e7fff7b07dcd98c17c418d8b4b22554da59a777cf742b0e3a7ab8677467b496bb4861746ae5f082b992a9962dac481e47277271c3f8792a1b8